Managing SEND Just Got Easier

We are excited to introduce SEND Advantage™ Services. Offering study conversions, compliance services and consulting, our new and refreshed services have been designed to help organizations maintain SEND compliance and more. Watch our on-demand video right now.

Watch Now

Drug Target Review Interviews Instem CSO

Instem CSO, Dr Gordon Baxter, was recently interviewed by Drug Target Review
for an in-depth editorial on Target Safety Assessment.

Download the article

Flash Demo: Introducing BioRails
ADME/DMPK Optimization

Watch the demo

Industry Insights

Join the journey with us by visiting
one of our bi-weekly industry Blogs

Learn More

We enable our clients to bring their life enhancing products to market faster


Latest News

Instem Awarded EMA Research Grant

Instem Secures Portion of €2.5m Grant as Member of Research Consortium Investigating the Mutagenicity of N-nitrosamines

Read More

Instem Expands In Silico Toxicology Service To Meet Growing Demand

Newly Added Services to Support Latest Regulatory Guidance and Growing Demand for Alternative Testing Methods

Read More

Instem Acquires PDS Life Sciences to Help Clients Bring Life Enhancing Products to Market Faster and More Efficiently

Acquisition of PDS Life Sciences Consolidates Non-Clinical Market; Further Extends Instem’s Leadership in Study Management and Regulatory SEND Submission Support

Read More

Virtual Appointment

Request a quote

Virtual Appointment

To help you better evaluate our software or services, we believe an initial, no pressure Web session is the way to go.

Request a quote

We are excited that you have decided to take the next step with Instem. To provide you with an accurate quotation, we ask that you fill out our form.